Maryland charges Insys engaged in deceptive opioid scheme
September 06, 2018 at 12:28 PM EDT
Maryland on Thursday charged Insys Therapeutics Inc with having engaged in deceptive practices that resulted in a powerful opioid medication the drugmaker produced that was meant for cancer patients being prescribed to other people.